Report cover image

Acute Ischemic Stroke Diagnosis Market by Diagnostics (Carotid Ultrasound, Cerebral Angiography, Computed Tomography), End-Use (Hospitals, Research & Diagnostic Centers) - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 193 Pages
SKU # IRE18417897

Description

Acute Ischemic Stroke Diagnosis Market by Diagnostics (Carotid Ultrasound, Cerebral Angiography, Computed Tomography), End-Use (Hospitals, Research & Diagnostic Centers) - Global Forecast 2024-2030


The Acute Ischemic Stroke Diagnosis Market size was estimated at USD 1.98 billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 6.15% to reach USD 3.02 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Acute Ischemic Stroke Diagnosis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Acute Ischemic Stroke Diagnosis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Acute Ischemic Stroke Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BIOTRONIK SE & Co KG, Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Canon Medical Systems Corporation, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., Genentech, Inc., Hitachi, Ltd., Integral Diagnostics (IDX) Group, Koninklijke Philips N.V., Mediso Kft., Medtronic PLC, Memorial Health, Neusoft Medical Systems Co., Ltd., Nihon Kohden Corporation, Planmed Oy, Samsung Electronics Co. Ltd, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers company, Stryker Corporation, and Toshiba International Corporation.

Market Segmentation & Coverage

This research report categorizes the Acute Ischemic Stroke Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

Diagnostics

Carotid Ultrasound
  • Cerebral Angiography
  • Computed Tomography
  • Echocardiography
  • Electrocardiography
  • Magnetic Resonance Imaging
  • End-Use

    Hospitals
  • Research & Diagnostic Centers
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Acute Ischemic Stroke Diagnosis Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Acute Ischemic Stroke Diagnosis Market?
    3. What are the technology trends and regulatory frameworks in the Acute Ischemic Stroke Diagnosis Market?
    4. What is the market share of the leading vendors in the Acute Ischemic Stroke Diagnosis Market?
    5. Which modes and strategic moves are suitable for entering the Acute Ischemic Stroke Diagnosis Market?


    Note: PDF & Excel + Online Access - 1 Year

    • Table of Contents

    193 Pages
    1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Acute Ischemic Stroke Diagnosis Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Increasing number of acute stroke cases all over the globe
    5.1.1.2. High preference for early clinical diagnostics among consumers
    5.1.1.3. Rising growth of neurological imaging and diagnostics facilities
    5.1.2. Restraints
    5.1.2.1. Associated high cost of diagnostic equipments
    5.1.3. Opportunities
    5.1.3.1. Integration of robotics and AI for advanced diagnostics
    5.1.3.2. Ongoing research and development activities for advanced diagnostics
    5.1.4. Challenges
    5.1.4.1. Dearth of technical expertise and practical experience
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Acute Ischemic Stroke Diagnosis Market, by Diagnostics
    6.1. Introduction
    6.2. Carotid Ultrasound
    6.3. Cerebral Angiography
    6.4. Computed Tomography
    6.5. Echocardiography
    6.6. Electrocardiography
    6.7. Magnetic Resonance Imaging
    7. Acute Ischemic Stroke Diagnosis Market, by End-Use
    7.1. Introduction
    7.2. Hospitals
    7.3. Research & Diagnostic Centers
    8. Americas Acute Ischemic Stroke Diagnosis Market
    8.1. Introduction
    8.2. Argentina
    8.3. Brazil
    8.4. Canada
    8.5. Mexico
    8.6. United States
    9. Asia-Pacific Acute Ischemic Stroke Diagnosis Market
    9.1. Introduction
    9.2. Australia
    9.3. China
    9.4. India
    9.5. Indonesia
    9.6. Japan
    9.7. Malaysia
    9.8. Philippines
    9.9. Singapore
    9.10. South Korea
    9.11. Taiwan
    9.12. Thailand
    9.13. Vietnam
    10. Europe, Middle East & Africa Acute Ischemic Stroke Diagnosis Market
    10.1. Introduction
    10.2. Denmark
    10.3. Egypt
    10.4. Finland
    10.5. France
    10.6. Germany
    10.7. Israel
    10.8. Italy
    10.9. Netherlands
    10.10. Nigeria
    10.11. Norway
    10.12. Poland
    10.13. Qatar
    10.14. Russia
    10.15. Saudi Arabia
    10.16. South Africa
    10.17. Spain
    10.18. Sweden
    10.19. Switzerland
    10.20. Turkey
    10.21. United Arab Emirates
    10.22. United Kingdom
    11. Competitive Landscape
    11.1. FPNV Positioning Matrix
    11.2. Market Share Analysis, By Key Player
    11.3. Competitive Scenario Analysis, By Key Player
    12. Competitive Portfolio
    12.1. Key Company Profiles
    12.1.1. Abbott Laboratories
    12.1.2. BIOTRONIK SE & Co KG
    12.1.3. Boehringer Ingelheim International GmbH
    12.1.4. Boston Scientific Corporation
    12.1.5. Canon Medical Systems Corporation
    12.1.6. F. Hoffmann-La Roche Ltd
    12.1.7. Fujifilm Holdings Corporation
    12.1.8. GE Healthcare Technologies Inc.
    12.1.9. Genentech, Inc.
    12.1.10. Hitachi, Ltd.
    12.1.11. Integral Diagnostics (IDX) Group
    12.1.12. Koninklijke Philips N.V.
    12.1.13. Mediso Kft.
    12.1.14. Medtronic PLC
    12.1.15. Memorial Health
    12.1.16. Neusoft Medical Systems Co., Ltd.
    12.1.17. Nihon Kohden Corporation
    12.1.18. Planmed Oy
    12.1.19. Samsung Electronics Co. Ltd
    12.1.20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    12.1.21. Shimadzu Corporation
    12.1.22. Siemens Healthineers company
    12.1.23. Stryker Corporation
    12.1.24. Toshiba International Corporation
    12.2. Key Product Portfolio
    13. Appendix
    13.1. Discussion Guide
    13.2. License & Pricing
    FIGURE 1. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET RESEARCH PROCESS
    FIGURE 2. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET DYNAMICS
    FIGURE 7. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2023 VS 2030 (%)
    FIGURE 8. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY DIAGNOSTICS, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
    FIGURE 10. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 12. AMERICAS ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 14. UNITED STATES ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 16. ASIA-PACIFIC ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 20. ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us